Max Healthcare Institute Ltd

Max Healthcare Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Max Healthcare Institute Ltd

₹ 803 -0.03%
26 Apr - close price
maxhealthcare.in BSE: 543220 NSE : MAXHEALTH
About

Max Healthcare Institute Limited is primarily engaged in the providing healthcare services through primary care clinics, multi-speciality hospitals / medical centres and super-speciality hospitals providing operation and management, medical services, clinical, radiology, pathology services and related healthcare services. [1]

Key Points

Leadership[1]
Max Healthcare is India’s second largest hospital chain in terms of revenue, EBITDA and market capitalisation.

Website BSE NSE
  • Market Cap ₹ 78,064 Cr.
  • Current Price ₹ 803
  • High / Low ₹ 910 / 460
  • Stock P/E 137
  • Book Value ₹ 72.5
  • Dividend Yield 0.12 %
  • ROCE 8.51 %
  • ROE 10.4 %
  • Face Value ₹ 10.0
Edit ratios

Pros

  • Company is almost debt free.
  • Company has delivered good profit growth of 93.7% CAGR over last 5 years
  • Debtor days have improved from 63.8 to 26.9 days.

Cons

  • Stock is trading at 11.1 times its book value
  • Company has a low return on equity of 6.33% over last 3 years.
  • Promoter holding has decreased over last 3 years: -46.7%

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Sector: Healthcare Industry: Healthcare

Edit Columns
Loading peers table ...

Quarterly Results

Standalone Figures in Rs. Crores / View Consolidated

Dec 2020 Mar 2021 Jun 2021 Sep 2021 Dec 2021 Mar 2022 Jun 2022 Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023
346 331 500 462 398 393 440 474 482 507 544 597 591
283 278 376 353 294 298 317 322 328 354 384 394 391
Operating Profit 63 53 124 109 104 96 123 152 154 154 160 203 200
OPM % 18% 16% 25% 24% 26% 24% 28% 32% 32% 30% 29% 34% 34%
25 25 27 30 42 27 29 32 44 41 43 48 43
Interest 30 25 11 15 11 13 13 13 13 14 14 13 10
Depreciation 24 22 25 28 25 28 28 28 28 30 28 28 30
Profit before tax 35 31 115 96 110 82 111 144 157 151 161 210 203
Tax % 9% 76% 24% 23% 5% 19% 22% -149% 22% 16% 22% 23% 22%
32 7 88 75 104 67 87 359 122 126 126 161 158
EPS in Rs 0.35 0.07 0.91 0.77 1.07 0.69 0.90 3.70 1.26 1.30 1.30 1.66 1.63
Raw PDF

Profit & Loss

Standalone Figures in Rs. Crores / View Consolidated

Mar 2013 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 TTM
591 790 912 984 1,059 1,008 59 1,031 1,775 1,905 2,239
615 768 890 941 1,048 976 65 870 1,332 1,321 1,522
Operating Profit -24 22 22 43 11 31 -6 161 443 584 716
OPM % -4% 3% 2% 4% 1% 3% -10% 16% 25% 31% 32%
39 33 35 30 51 47 66 -104 128 144 174
Interest 42 43 30 35 41 44 60 112 59 52 50
Depreciation 31 49 50 51 49 53 3 91 112 113 115
Profit before tax -58 -38 -24 -13 -28 -18 -3 -146 400 563 725
Tax % 0% 0% 0% 0% 0% -26% 5% -12% 17% -23%
-58 -38 -24 -13 -28 -23 -3 -164 332 694 572
EPS in Rs -1.46 -0.78 -0.44 -0.24 -0.51 -0.43 -0.06 -1.70 3.42 7.15 5.89
Dividend Payout % 0% 0% 0% 0% 0% 0% 0% 0% 0% 14%
Compounded Sales Growth
10 Years: 12%
5 Years: 12%
3 Years: 218%
TTM: 25%
Compounded Profit Growth
10 Years: 30%
5 Years: 94%
3 Years: 518%
TTM: -10%
Stock Price CAGR
10 Years: %
5 Years: %
3 Years: 53%
1 Year: 75%
Return on Equity
10 Years: %
5 Years: 5%
3 Years: 6%
Last Year: 10%

Balance Sheet

Standalone Figures in Rs. Crores / View Consolidated

Mar 2013 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Equity Capital 395 489 533 537 537 537 537 966 970 971
Reserves 167 523 762 770 773 749 2,338 4,973 5,342 6,071
Preference Capital 125 0 0 0 0 0 0 0 0 0
380 296 273 314 386 390 658 480 556 534
348 141 171 210 278 274 20 724 945 845
Total Liabilities 1,290 1,449 1,740 1,832 1,973 1,951 3,553 7,143 7,812 8,420
468 430 424 429 502 479 90 2,989 4,493 4,485
CWIP 10 15 6 30 7 10 0 8 60 103
Investments 238 451 840 866 799 770 2,471 2,379 1,447 1,475
574 554 469 508 665 693 992 1,766 1,811 2,358
Total Assets 1,290 1,449 1,740 1,832 1,973 1,951 3,553 7,143 7,812 8,420

Cash Flows

Standalone Figures in Rs. Crores / View Consolidated

Mar 2013 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
39 64 33 52 -19 -36 224 447 696
-200 -330 -66 -89 55 -2,536 -105 -670 -843
176 251 34 36 -36 2,332 412 -161 -54
Net Cash Flow 15 -16 0 -0 -0 -240 532 -384 -201

Ratios

Standalone Figures in Rs. Crores / View Consolidated

Mar 2013 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Debtor Days 97 67 48 55 68 103 517 109 56 27
Inventory Days 18 20 18 19 22 25 33 20 31
Days Payable 158 171 183 206 250 335 297 159 226
Cash Conversion Cycle -42 -85 -117 -132 -161 -206 517 -155 -83 -169
Working Capital Days 27 3 2 4 -4 32 3,558 35 12 -39
ROCE % 0% 1% 1% 2% 2% 4% 7% 9%

Shareholding Pattern

Numbers in percentages

2 Recently
Jun 2021Sep 2021Dec 2021Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
70.46% 60.91% 60.68% 50.64% 50.64% 23.80% 23.78% 23.77% 23.76% 23.76% 23.75% 23.75%
14.05% 14.23% 16.67% 14.59% 23.34% 49.27% 50.15% 51.96% 59.89% 60.39% 60.69% 57.33%
7.95% 8.70% 15.67% 17.57% 19.42% 21.16% 20.47% 19.36% 11.90% 11.40% 11.55% 14.96%
7.54% 16.16% 6.97% 17.20% 6.61% 5.76% 5.61% 4.92% 4.45% 4.45% 3.99% 3.97%
No. of Shareholders 70,65591,9371,11,8771,20,0791,05,0001,01,6591,11,7011,04,6561,11,3741,18,6351,11,3381,27,009

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports

Credit ratings

Concalls